PKI-166
PKI-166 is a potent and selective oral EGF-R tyrosine kinase inhibitor (IC50: 0.7 nM) . It has demonstrated efficacy in inhibiting the growth and metastasis of various human cancer cell lines, including pancreatic cancer, in both in vitro and in vivo preclinical studies.
Product Specifications
CAS Number
187724-61-4
Product Name Alternative
EGFR tyrosine kinase, PKI 166, PKI166, PKI-166, VEGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.20% (May vary between batches)
Solubility
DMSO:27.5 mg/mL (83.24 mM)
Smiles
C[C@@H] (Nc1ncnc2[nH]c (cc12) -c1ccc (O) cc1) c1ccccc1
Molecular Formula
C20H18N4O
Molecular Weight
330.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15373779 1 Vial
Lentiviral human WRAP53 sgRNA gene knockout kit - Lentiviral human WRAP53 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 
E3230 96 Tests
Inter-α-Trypsin Inhibitor heavy chain H1 (ITIH1) Porcine ELISA Kit
Sign In for Pricing
View Details MBS6220783-01 0.1 mL
ADK (Adenosine Kinase, AK, Adenosine 5'-phosphotransferase) (MaxLight 650)
Sign In for Pricing
View Details